Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
1.
Channels (Austin) ; 18(1): 2338782, 2024 Dec.
Article in English | MEDLINE | ID: mdl-38691022

ABSTRACT

L-type calcium channels are essential for the excitation-contraction coupling in cardiac muscle. The CaV1.2 channel is the most predominant isoform in the ventricle which consists of a multi-subunit membrane complex that includes the CaV1.2 pore-forming subunit and auxiliary subunits like CaVα2δ and CaVß2b. The CaV1.2 channel's C-terminus undergoes proteolytic cleavage, and the distal C-terminal domain (DCtermD) associates with the channel core through two domains known as proximal and distal C-terminal regulatory domain (PCRD and DCRD, respectively). The interaction between the DCtermD and the remaining C-terminus reduces the channel activity and modifies voltage- and calcium-dependent inactivation mechanisms, leading to an autoinhibitory effect. In this study, we investigate how the interaction between DCRD and PCRD affects the inactivation processes and CaV1.2 activity. We expressed a 14-amino acid peptide miming the DCRD-PCRD interaction sequence in both heterologous systems and cardiomyocytes. Our results show that overexpression of this small peptide can displace the DCtermD and replicate the effects of the entire DCtermD on voltage-dependent inactivation and channel inhibition. However, the effect on calcium-dependent inactivation requires the full DCtermD and is prevented by overexpression of calmodulin. In conclusion, our results suggest that the interaction between DCRD and PCRD is sufficient to bring about the current inhibition and alter the voltage-dependent inactivation, possibly in an allosteric manner. Additionally, our data suggest that the DCtermD competitively modifies the calcium-dependent mechanism. The identified peptide sequence provides a valuable tool for further dissecting the molecular mechanisms that regulate L-type calcium channels' basal activity in cardiomyocytes.


Subject(s)
Calcium Channels, L-Type , Myocytes, Cardiac , Calcium Channels, L-Type/metabolism , Calcium Channels, L-Type/genetics , Calcium Channels, L-Type/chemistry , Animals , Myocytes, Cardiac/metabolism , Humans , HEK293 Cells , Rats , Protein Domains
2.
Cells ; 9(12)2020 12 04.
Article in English | MEDLINE | ID: mdl-33291797

ABSTRACT

Functional and morphological modifications in the brain caused by major mood disorders involve many brain areas, including the hippocampus, leading to cognitive and mood alterations. Cav1.2 channel expression has been found to increase in animals with depressive-like behaviors. Calcium influx through these channels is associated with changes in excitation-transcriptional coupling by several intracellular signal pathways that are regulated by its C-terminus region. However, which of these signaling pathways is activated during the development of depressive-like behaviors is not known. Here, we evaluate the phosphorylation and expression levels of crucial kinases and transcription factors at the hippocampus of rats after 21 days of chronic restraint stress. Our results show that rats subjected to CRS protocol achieve less body weight, have heavier adrenal glands, and exhibit depression-like behaviors such as anhedonia, behavioral despair and decreased social interaction. Cav1.2 mRNA and protein expression levels, plus l-type calcium current amplitude, are also increased in treated rats when compared with control animals. Out of the three main signaling pathways activated by l-type currents, we only observed an increment of CaM-NFAT axis activity with the concomitant increment in Fas ligand expression. Thus, our results suggest that CRS activates specific pathways, and the increased expression of Cav1.2 could lead to neuronal death in the hippocampus.


Subject(s)
Calcium Channels, L-Type/metabolism , Depression/physiopathology , Hippocampus/metabolism , Signal Transduction , Adrenal Glands , Anhedonia , Animals , Behavior, Animal , Body Weight , Calcium/metabolism , Depressive Disorder, Major/metabolism , Disease Models, Animal , Gene Expression Profiling , Ligands , Male , Neurons/metabolism , Phosphorylation , Protein Domains , Rats , Rats, Sprague-Dawley , Swimming
3.
J Gen Physiol ; 151(6): 786-797, 2019 06 03.
Article in English | MEDLINE | ID: mdl-30814137

ABSTRACT

The activity of L-type calcium channels is associated with the duration of the plateau phase of the cardiac action potential (AP) and it is controlled by voltage- and calcium-dependent inactivation (VDI and CDI, respectively). During ß-adrenergic stimulation, an increase in the L-type current and parallel changes in VDI and CDI are observed during square pulses stimulation; however, how these modifications impact calcium currents during an AP remains controversial. Here, we examined the role of both inactivation processes on the L-type calcium current activity in newborn rat cardiomyocytes in control conditions and after stimulation with the ß-adrenergic agonist isoproterenol. Our approach combines a self-AP clamp (sAP-Clamp) with the independent inhibition of VDI or CDI (by overexpressing CaVß2a or calmodulin mutants, respectively) to directly record the L-type calcium current during the cardiac AP. We find that at room temperature (20-23°C) and in the absence of ß-adrenergic stimulation, the L-type current recapitulates the AP kinetics. Furthermore, under our experimental setting, the activity of the sodium-calcium exchanger (NCX) does not affect the shape of the AP. We find that hindering either VDI or CDI prolongs the L-type current and the AP in parallel, suggesting that both inactivation processes modulate the L-type current during the AP. In the presence of isoproterenol, wild-type and VDI-inhibited cardiomyocytes display mismatched L-type calcium current with respect to their AP. In contrast, CDI-impaired cells maintain L-type current with kinetics similar to its AP, demonstrating that calcium-dependent inactivation governs L-type current kinetics during ß-adrenergic stimulation.


Subject(s)
Action Potentials/drug effects , Action Potentials/physiology , Adrenergic beta-Agonists/pharmacology , Calcium Channels, L-Type/metabolism , Calcium/metabolism , Heart/drug effects , Animals , Ion Transport/drug effects , Ion Transport/physiology , Isoproterenol/pharmacology , Myocytes, Cardiac/drug effects , Myocytes, Cardiac/metabolism , Rats , Rats, Sprague-Dawley , Sodium-Calcium Exchanger/metabolism
4.
Sci Rep ; 7(1): 10131, 2017 08 31.
Article in English | MEDLINE | ID: mdl-28860469

ABSTRACT

The cardiac L-type calcium channel is a multi-subunit complex that requires co-assembling of the pore-forming subunit CaV1.2 with auxiliary subunits CaVα2δ and CaVß. Its traffic has been shown to be controlled by these subunits and by the activation of various G-protein coupled receptors (GPCR). Here, we explore the consequences of the prolonged activation of angiotensin receptor type 1 (AT1R) over CaV1.2 channel trafficking. Bioluminescence Resonance Energy Transfer (BRET) assay between ß-arrestin and L-type channels in angiotensin II-stimulated cells was used to assess the functional consequence of AT1R activation, while immunofluorescence of adult rat cardiomyocytes revealed the effects of GPCR activation on CaV1.2 trafficking. Angiotensin II exposure results in ß-arrestin1 recruitment to the channel complex and an apparent loss of CaV1.2 immunostaining at the T-tubules. Accordingly, angiotensin II stimulation causes a decrease in L-type current, Ca2+ transients and myocyte contractility, together with a faster repolarization phase of action potentials. Our results demonstrate that prolonged AT1R activation induces ß-arrestin1 recruitment and the subsequent internalization of CaV1.2 channels with a half-dose of AngII on the order of 100 nM, suggesting that this effect depends on local renin-angiotensin system. This novel AT1R-dependent CaV1.2-trafficking modulation likely contributes to angiotensin II-mediated cardiac remodeling.


Subject(s)
Calcium Channels, L-Type/metabolism , Myocytes, Cardiac/metabolism , Receptor, Angiotensin, Type 1/metabolism , Action Potentials , Animals , Calcium Signaling , Cell Line , Cells, Cultured , Humans , Male , Myocytes, Cardiac/physiology , Protein Transport , Rats , Rats, Sprague-Dawley , beta-Arrestins/metabolism
5.
Pflugers Arch ; 467(12): 2473-84, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26265381

ABSTRACT

In the heart, the main pathway for calcium influx is mediated by L-type calcium channels, a multi-subunit complex composed of the pore-forming subunit CaV1.2 and the auxiliary subunits CaVα2δ1 and CaVß2. To date, five distinct CaVß2 transcriptional start site (TSS) variants (CaVß2a-e) varying only in the composition and length of the N-terminal domain have been described, each of them granting distinct biophysical properties to the L-type current. However, the physiological role of these variants in Ca(2+) handling in the native tissue has not been explored. Our results show that four of these variants are present in neonatal rat cardiomyocytes. The contribution of those CaVß2 TSS variants on endogenous L-type current and Ca(2+) handling was explored by adenoviral-mediated overexpression of each CaVß2 variant in cultured newborn rat cardiomyocytes. As expected, all CaVß2 TSS variants increased L-type current density and produced distinctive changes on L-type calcium channel (LTCC) current activation and inactivation kinetics. The characteristics of the induced calcium transients were dependent on the TSS variant overexpressed. Moreover, the amplitude of the calcium transients varied depending on the subunit involved, being higher in cardiomyocytes transduced with CaVß2a and smaller in CaVß2d. Interestingly, the contribution of Ca(2+) influx and Ca(2+) release on total calcium transients, as well as the sarcoplasmic calcium content, was found to be TSS-variant-dependent. Remarkably, determination of atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) messenger RNA (mRNA) abundance and cell size change indicates that CaVß2 TSS variants modulate the cardiomyocyte hypertrophic state. In summary, we demonstrate that expression of individual CaVß2 TSS variants regulates calcium handling in cardiomyocytes and, consequently, has significant repercussion in the development of hypertrophy.


Subject(s)
Calcium Channels, L-Type/metabolism , Calcium Signaling , Myocytes, Cardiac/metabolism , Transcription Initiation Site , Action Potentials , Animals , Calcium Channels, L-Type/genetics , Cells, Cultured , Heart Ventricles/cytology , Heart Ventricles/growth & development , Myocytes, Cardiac/physiology , Rats
6.
PLoS One ; 9(4): e94146, 2014.
Article in English | MEDLINE | ID: mdl-24710004

ABSTRACT

The pathogenesis of systemic inflammatory diseases, including endotoxemia-derived sepsis syndrome, is characterized by endothelial dysfunction. It has been demonstrated that the endotoxin lipopolysaccharide (LPS) induces the conversion of endothelial cells (ECs) into activated fibroblasts through endothelial-to-mesenchymal transition mechanism. Fibrogenesis is highly dependent on intracellular Ca2+ concentration increases through the participation of calcium channels. However, the specific molecular identity of the calcium channel that mediates the Ca2+ influx during endotoxin-induced endothelial fibrosis is still unknown. Transient receptor potential melastatin 7 (TRPM7) is a calcium channel that is expressed in many cell types, including ECs. TRPM7 is involved in a number of crucial processes such as the conversion of fibroblasts into activated fibroblasts, or myofibroblasts, being responsible for the development of several characteristics of them. However, the role of the TRPM7 ion channel in endotoxin-induced endothelial fibrosis is unknown. Thus, our aim was to study whether the TRPM7 calcium channel participates in endotoxin-induced endothelial fibrosis. Using primary cultures of ECs, we demonstrated that TRPM7 is a crucial protein involved in endotoxin-induced endothelial fibrosis. Suppression of TRPM7 expression protected ECs from the fibrogenic process stimulated by endotoxin. Downregulation of TRPM7 prevented the endotoxin-induced endothelial markers decrease and fibrotic genes increase in ECs. In addition, TRPM7 downregulation abolished the endotoxin-induced increase in ECM proteins in ECs. Furthermore, we showed that intracellular Ca2+ levels were greatly increased upon LPS challenge in a mechanism dependent on TRPM7 expression. These results demonstrate that TRPM7 is a key protein involved in the mechanism underlying endotoxin-induced endothelial fibrosis.


Subject(s)
Endotoxins/toxicity , Human Umbilical Vein Endothelial Cells/drug effects , Human Umbilical Vein Endothelial Cells/pathology , TRPM Cation Channels/metabolism , Biomarkers/metabolism , Calcium/metabolism , Extracellular Matrix Proteins/metabolism , Fibroblasts/cytology , Fibroblasts/drug effects , Fibroblasts/metabolism , Fibrosis , Gene Expression Regulation/drug effects , Human Umbilical Vein Endothelial Cells/metabolism , Humans , Intracellular Space/drug effects , Intracellular Space/metabolism , Lipopolysaccharides/pharmacology , Protein Serine-Threonine Kinases
7.
Channels (Austin) ; 5(3): 280-6, 2011.
Article in English | MEDLINE | ID: mdl-21525790

ABSTRACT

Angiotensin II regulation of L-type calcium currents in cardiac muscle is controversial and the underlying signaling events are not completely understood. Moreover, the possible role of auxiliary subunit composition of the channels in Angiotensin II modulation of L-type calcium channels has not yet been explored. In this work we study the role of Ca(v)ß subunits and the intracellular signaling responsible for L-type calcium current modulation by Angiotensin II. In cardiomyocytes, Angiotensin II exposure induces rapid inhibition of L-type current with a magnitude that is correlated with the rate of current inactivation. Semi-quantitative PCR of cardiomyocytes at different days of culture reveals changes in the Ca(v)ß subunits expression pattern that are correlated with the rate of current inactivation and with Angiotensin II effect. Over-expression of individual b subunits in heterologous systems reveals that the magnitude of Angiotensin II inhibition is dependent on the Ca(v)ß subunit isoform, with Ca(v)ß(1b) containing channels being more strongly regulated. Ca(v)ß(2a) containing channels were insensitive to modulation and this effect was partially due to the N-terminal palmitoylation sites of this subunit. Moreover, PLC or diacylglycerol lipase inhibition prevents the Angiotensin II effect on L-type calcium channels, while PKC inhibition with chelerythrine does not, suggesting a role of arachidonic acid in this process. Finally, we show that in intact cardiomyocytes the magnitude of calcium transients on spontaneous beating cells is modulated by Angiotensin II in a Ca(v)ß subunit-dependent manner. These data demonstrate that Ca(v)ß subunits alter the magnitude of inhibition of L-type current by Angiotensin II.


Subject(s)
Angiotensin II/metabolism , Calcium Channels, L-Type/metabolism , Gene Expression Regulation/physiology , Membrane Potentials/physiology , Muscle Proteins/metabolism , Myocytes, Cardiac/metabolism , Angiotensin II/pharmacology , Animals , Anti-Bacterial Agents/pharmacology , Arachidonic Acid/metabolism , Benzophenanthridines/pharmacology , Cell Line , Gene Expression Regulation/drug effects , Lipoprotein Lipase/pharmacology , Lipoylation/drug effects , Lipoylation/physiology , Membrane Potentials/drug effects , Muscle Proteins/antagonists & inhibitors , Muscle Proteins/genetics , Myocytes, Cardiac/cytology , Phosphoinositide Phospholipase C/pharmacology , Protein Kinase C/antagonists & inhibitors , Protein Kinase C/metabolism , Rats , Rats, Sprague-Dawley , Vasoconstrictor Agents/metabolism , Vasoconstrictor Agents/pharmacology
8.
Nat Neurosci ; 14(2): 173-80, 2011 Feb.
Article in English | MEDLINE | ID: mdl-21186355

ABSTRACT

It is well established that the auxiliary Cavß subunit regulates calcium channel density in the plasma membrane, but the cellular mechanism by which this occurs has remained unclear. We found that the Cavß subunit increased membrane expression of Cav1.2 channels by preventing the entry of the channels into the endoplasmic reticulum-associated protein degradation (ERAD) complex. Without Cavß, Cav1.2 channels underwent robust ubiquitination by the RFP2 ubiquitin ligase and interacted with the ERAD complex proteins derlin-1 and p97, culminating in targeting of the channels to the proteasome for degradation. On treatment with the proteasomal inhibitor MG132, Cavß-free channels were rescued from degradation and trafficked to the plasma membrane. The coexpression of Cavß interfered with ubiquitination and targeting of the channel to the ERAD complex, thereby facilitating export from the endoplasmic reticulum and promoting expression on the cell surface. Thus, Cavßß regulates the ubiquitination and stability of the calcium channel complex.


Subject(s)
Calcium Channels, L-Type/metabolism , DNA-Binding Proteins/metabolism , Endoplasmic Reticulum/metabolism , Neurons/metabolism , Proteasome Endopeptidase Complex/metabolism , Protein Subunits/metabolism , Tumor Suppressor Proteins/metabolism , Ubiquitination/physiology , Analysis of Variance , Animals , Blotting, Western , Calcium Channels, L-Type/genetics , Cells, Cultured , DNA-Binding Proteins/genetics , Endoplasmic Reticulum/genetics , Enzyme-Linked Immunosorbent Assay , Hippocampus/cytology , Hippocampus/metabolism , Immunohistochemistry , Immunoprecipitation , Membrane Proteins/genetics , Membrane Proteins/metabolism , Microscopy, Confocal , Neurons/cytology , Proteasome Endopeptidase Complex/genetics , Protein Subunits/genetics , Rats , TNF Receptor-Associated Factor 2 , Transfection , Tumor Necrosis Factor Receptor-Associated Peptides and Proteins/genetics , Tumor Necrosis Factor Receptor-Associated Peptides and Proteins/metabolism , Tumor Suppressor Proteins/genetics , Ubiquitin/genetics , Ubiquitin/metabolism
9.
Biochem Biophys Res Commun ; 375(3): 372-7, 2008 Oct 24.
Article in English | MEDLINE | ID: mdl-18713622

ABSTRACT

We have generated a syntaxin 1A knockout mouse by deletion of exons 3 through 6 and a concomitant insertion of a stop codon in exon 2. Heterozygous knockout animals were viable with no apparent phenotype. In contrast, the vast majority of homozygous animals died in utero, with embryos examined at day E15 showing a drastic reduction in body size and development when compared to WT and heterozygous littermates. Surprisingly, out of a total of 204 offspring from heterozygous breeding pairs only four homozygous animals were born alive and viable. These animals exhibited reduced body weight, but showed only mild behavioral deficiencies. Taken together, our data indicate that syntaxin 1A is an important regulator of normal in utero development, but may not be essential for normal brain function later in life.


Subject(s)
Embryonic Development , Fetal Death , Syntaxin 1/physiology , Uterus/physiology , Animals , Codon, Terminator/genetics , Embryonic Development/genetics , Exons/genetics , Female , Fetal Death/genetics , Fetal Weight/genetics , Humans , Mice , Mice, Knockout , Rats , Sequence Deletion , Syntaxin 1/genetics
10.
Biochim Biophys Acta ; 1783(6): 1111-20, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18346467

ABSTRACT

Thy-1 is an abundant neuronal glycoprotein of poorly defined function. We recently provided evidence indicating that Thy-1 clusters a beta3-containing integrin in astrocytes to induce tyrosine phosphorylation, RhoA activation and the formation of focal adhesions and stress fibers. To date, the alpha subunit partner of beta3 integrin in DI TNC1 astrocytes is unknown. Similarly, the ability of neuronal, membrane-bound Thy-1 to trigger astrocyte signaling via integrin engagement remains speculation. Here, evidence that alphav forms an alphavbeta3 heterodimer in DI TNC1 astrocytes was obtained. In neuron-astrocyte association assays, the presence of either anti-alphav or anti-beta3 integrin antibodies reduced cell-cell interaction demonstrating the requirement of both integrin subunits for this association. Moreover, anti-Thy-1 antibodies blocked stimulation of astrocytes by neurons but not the binding of these two cell types. Thus, neuron-astrocyte association involved binding between molecular components in addition to the Thy-1-integrin; however, the signaling events leading to focal adhesion formation in astrocytes depended exclusively on the latter interaction. Additionally, wild-type (RLD) but not mutated (RLE) Thy-1 was shown to directly interact with alphavbeta3 integrin by Surface Plasmon Resonance analysis. This interaction was promoted by divalent cations and was species-independent. Together, these results demonstrate that the alphavbeta3 integrin heterodimer interacts directly with Thy-1 present on neuronal cells to stimulate astrocytes.


Subject(s)
Astrocytes/physiology , Cell Communication , Integrin alphaVbeta3/metabolism , Neurons/physiology , Thy-1 Antigens/metabolism , Animals , Astrocytes/cytology , Blotting, Western , Cell Adhesion/physiology , Cells, Cultured , Fluorescent Antibody Technique, Indirect , Humans , Immunoprecipitation , Mice , Neurons/cytology , Rats , Recombinant Proteins/genetics , Recombinant Proteins/isolation & purification , Recombinant Proteins/metabolism , Surface Plasmon Resonance , rhoA GTP-Binding Protein/metabolism
11.
Mol Pharmacol ; 73(6): 1589-91, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18326584

ABSTRACT

T-type calcium channels are important for a variety of physiological processes such as brain and heart function. Proper regulation of these channels by second messengers is fundamental; however, our knowledge of the molecular pathways that regulate T-type calcium channels is limited in comparison with other voltage-dependent calcium channels. In this issue of Molecular Pharmacology, Tao et al. (p. 1596) demonstrate that Cav3.2 is regulated by activation of the corticotropin-releasing factor receptor 1 in a Gbetagamma-dependent manner.


Subject(s)
Calcium Channel Blockers/pharmacology , Calcium Channels, T-Type/metabolism , Corticotropin-Releasing Hormone/pharmacology , Corticotropin-Releasing Hormone/physiology , Animals , Calcium Channels, T-Type/biosynthesis , Calcium Channels, T-Type/chemistry , Humans
12.
Peptides ; 27(1): 95-104, 2006 Jan.
Article in English | MEDLINE | ID: mdl-16139931

ABSTRACT

Incorporation of Alzheimer's disease amyloid beta-proteins (AbetaPs) across natural and artificial bilayer membranes leads to the formation of cation-selective channels. To study the peptide-membrane interactions involved in channel formation, we used cation reporter dyes to measure AbetaP-induced influx of Na+, Ca2+, and K+ into liposomes formed from phosphatidylserine (PS), phosphatidylinositol (PI) and phosphatidylcholine (PC). We found that Abeta40, but not Abeta40-1 or Abeta28, caused a dose-dependent increase in the concentration of each cation in the lumen of liposomes formed from the acidic phospholipids PS and PI. The Abeta40-induced changes in cation concentration, which we attribute to ion entry through Abeta40 channels, were not observed when using liposomes formed from the neutral phospholipid PC. Using mixtures of phospholipids, the magnitude of the AbetaP40-induced ion entry increased with the acidic phospholipid content of the liposomes, with entry being observed with as little as 5% PS or PI. Thus, while negatively charged phospholipids are required for formation of cation-permeable channels by Abeta40, a small amount is sufficient to support the process. These results have implications for the mechanisms of AbetaP cytotoxicity, suggesting that even a small amount of externalized negative charge could render cells susceptible to the deleterious effects of unregulated ion influx through AbetaP channels.


Subject(s)
Alzheimer Disease/metabolism , Amyloid beta-Peptides/metabolism , Ion Channels/metabolism , Liposomes/metabolism , Peptide Fragments/metabolism , Phospholipids/physiology , Amyloid beta-Peptides/physiology , Amyloid beta-Peptides/toxicity , Anions/metabolism , Calcium/metabolism , Humans , Hydrogen-Ion Concentration , Peptide Fragments/physiology , Peptide Fragments/toxicity , Phosphatidylcholines/physiology , Phosphatidylinositols/physiology , Phosphatidylserines/physiology , Sodium/metabolism , Spectrometry, Fluorescence
SELECTION OF CITATIONS
SEARCH DETAIL
...